Antioxidant enzyme systems and metallothionein pathway in retinal pigment epithelial cells (RPE antioxidant/MT pathway)

The antioxidant enzyme systems and metallothionein pathway in retinal pigment epithelial (RPE) cells represent a complex network of proteins dedicated to maintaining redox homeostasis in the retina (PMID: 12657593). RPE cells are uniquely vulnerable to oxidative stress due to their high metabolic rate, constant exposure to light, and the phagocytosis of lipid-rich photoreceptor outer segments. Primary antioxidant enzymes involved include superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), which neutralize reactive oxygen species (ROS) generated during visual cycle processes (PMID: 15135313). Metallothioneins (MTs) complement these enzymes by regulating zinc homeostasis and scavenging free radicals, thereby protecting the RPE from heavy metal toxicity and photo-oxidative damage (PMID: 15615933). Impairment of these pathways is a primary driver of age-related macular degeneration (AMD), where cumulative oxidative damage leads to RPE atrophy and subsequent vision loss (PMID: 11064120). Pharmacological interventions, such as those evaluated in the AREDS trials, focus on enhancing these systems through nutritional supplementation or Nrf2 activators to preserve RPE health and prevent retinal degeneration.

Other names

RPE antioxidant defense systemRetinal pigment epithelium redox homeostasisMetallothionein-mediated cytoprotection in RPERPE oxidative stress response pathway

Therapeutic agents typically act by directly scavenging reactive oxygen species (ROS), providing essential metal cofactors like zinc to stabilize metallothioneins, or inducing the expression of endogenous antioxidant enzymes through the activation of the Nrf2 (Nuclear factor erythroid 2-related factor 2) signaling pathway (PMID: 25634361, 15135313).